issued 10th february 2005 london preliminary announcement of results for the year ended 31st december 2004 gsk delivers eps in line with guidance and confirms return to growth glaxosmithkline plc today announces its full uk gaap are presented under profit loss account on pages 8 9 summarised below financial q4 m cer turnover 20 359 1 5 333 3 business performance trading 6 150 11 282 7 13 before tax 119 2 390 17 earnings per share 75 0p 16 8p 15 statutory 34 24 31 22 following a european union regulation 2002 will move reporting accordance international standards ifrs from 1st january information purposes restated onto an basis page
